Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OTC Statin Target Population Receives Significant FDA Attention

This article was originally published in The Tan Sheet

Executive Summary

The type of people most suited for OTC statin therapy received considerable attention from FDA during the agency's discussion on the OTC availability of vascular drugs at a public meeting in Gaithersburg, Md. June 28-29.

You may also be interested in...



OTC Switch Expert Panels Supported By AHA

The American Heart Association supports establishing expert panels that would determine what additional research is needed before a decision on a potential switch candidate can be made. The association's comments refer specifically to statin drugs.

OTC Switch Expert Panels Supported By AHA

The American Heart Association supports establishing expert panels that would determine what additional research is needed before a decision on a potential switch candidate can be made. The association's comments refer specifically to statin drugs.

OTC Switch Expert Panels Supported By AHA

The American Heart Association supports establishing expert panels that would determine what additional research is needed before a decision on a potential switch candidate can be made. The association's comments refer specifically to statin drugs.

Related Content

Topics

UsernamePublicRestriction

Register

ID1131516

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel